2023-09-21
04:03 |
|
3 p, 1.3 MB |
Vaccine hesitancy and access to psoriasis care during the -19 pandemic : findings from a global patient-reported cross-sectional survey
/
Bechman, Katie (King's College London) ;
Cook, Emma S. (King's College London) ;
Dand, Nick (Health Data Research UK) ;
Yiu, Zenas Z.N. (The University of Manchester) ;
Tsakok, Teresa (King's College London) ;
Meynell, Freya (King's College London) ;
Coker, Bolaji (King's College London) ;
Vincent, Alexandra (King's College London) ;
Bachelez, Hervé (Université de Paris) ;
Barbosa, Ines (King's College London) ;
Brown, Matthew A. (King's College London) ;
Capon, Francesca (King's College London) ;
Contreras, Claudia R. (Universidad Nacional de Asuncion) ;
De La Cruz, Claudia (Clinica Dermacross) ;
Meglio, Paola Di (King's College London) ;
Gisondi, Paolo (University of Verona) ;
Jullien, Denis (Groupe de recherche sur le psoriasis (GrPso) de la Société Française de dermatologie) ;
Kelly, Jade (NIHR Manchester Biomedical Research Centre) ;
Lambert, Jo (Ghent University) ;
Lancelot, Camille (International Federation of Psoriasis Associations) ;
Langan, Sinead M. (London School of Hygiene and Tropical Medicine) ;
Mason, Kayleigh J. (Keele University) ;
McAteer, Helen (The Psoriasis Association) ;
Moorhead, Lucy (King's College London) ;
Naldi, Luigi (Centro Studi GISED) ;
Norton, Sam (King's College London) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Spuls, Phyllis I. (Amsterdam University Medical Centers) ;
Torres, Tiago (Centro Hospitalar do Porto) ;
Urmston, Dominic (The Psoriasis Association) ;
Vesty, Amber (The Psoriasis Association) ;
Warren, Richard B. (NIHR Manchester Biomedical Research Centre) ;
Waweru, Hoseah (International Federation of Psoriasis Associations) ;
Weinman, John (King's College London) ;
Griffiths, Christopher E.M. (NIHR Manchester Biomedical Research Centre) ;
Barker, Jonathan N. (King's College London) ;
Smith, Catherine H. (King's College London) ;
Galloway, James B. (King's College London) ;
Mahil, Satveer K. (King's College London) ;
Universitat Autònoma de Barcelona
2022 -  10.1111/bjd.21042
British journal of dermatology, Vol. 187 (may 2022) , p. 254-256
|
|
2023-09-20
03:32 |
|
9 p, 1.0 MB |
Safinamide in the treatment pathway of Parkinson's Disease : a European Delphi Consensus
/
Stocchi, Fabrizio (University and IRCCS San Raffaele Pisana) ;
Antonini, Angelo (University of Padua) ;
Berg, Daniela (Hertie-Institute of Clinical Brain Research Tübingen) ;
Bergmans, Bruno (Ghent University Hospital. (Bèlgica)) ;
Jost, Wolfgang (Parkinson-Klinik Ortenau) ;
Katzenschlager, Regina (Neurodegenerative Disorders Klinik Donaustadt) ;
Kulisevsky, Jaime (Institut d'Investigació Biomèdica Sant Pau) ;
Odin, Per (Lund University) ;
Valldeoriola, Francesc (Hospital Clínic i Provincial de Barcelona) ;
Ray Chaudhuri, K. (King's College Hospital and Kings College) ;
Universitat Autònoma de Barcelona
Safinamide is a highly selective, reversible MAO B-inhibitor recently marketed in European and North American countries. To better define clinical indications regarding motor and non-motor symptoms, targeted population and safety of this compound, ten movement disorders specialists, experts in their field, convened and developed a panel of statements on: the role of glutamate in Parkinson's disease, introduction to fluctuations, efficacy of safinamide on motor symptoms, motor complications and non-motor symptoms, quality of life, safety of safinamide and target population for use. [...]
2022 - 10.1038/s41531-022-00277-z
NPJ Parkinson's disease, Vol. 8 (february 2022)
|
|
2023-09-16
04:14 |
|
12 p, 1.7 MB |
The development of a core outcomes set for self-management interventions for patients living with obesity
/
Valli, Claudia (Institut d'Investigació Biomèdica Sant Pau) ;
Suñol Sala, Rosa (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Orrego, Carola (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Niño de Guzmán, Ena Pery (Institut d'Investigació Biomèdica Sant Pau) ;
Strammiello, Valentina (European Patients' Forum (EPF)) ;
Adrion, Nina (OptiMedis AG) ;
Immonen, Kaisa (European Patients' Forum (EPF)) ;
Ninov, Lyudmil (European Patients' Forum (EPF)) ;
Van der Gaag, Marieke (Netherlands Institute for Health Services Research (NIVEL)) ;
Ballester, Marta (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau)
Self-management interventions (SMIs) can improve the life of patients living with obesity. However, there is variability in the outcomes used to assess the effectiveness of SMIs and these are often not relevant for patients. [...]
2021 - 10.1111/cob.12489
Clinical Obesity, Vol. 12 (october 2021)
|
|
2023-09-15
03:24 |
|
13 p, 2.0 MB |
Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI
/
Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Sutelman, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Ben-Aicha Gonzalez, Soumaya (Institut d'Investigació Biomèdica Sant Pau) ;
Mendieta, Guiomar (Institut d'Investigació Biomèdica Sant Pau) ;
Radiké, Monika (Institut d'Investigació Biomèdica Sant Pau) ;
Schoch, Leonie (Institut d'Investigació Biomèdica Sant Pau) ;
Casaní, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Borrell-Pages, Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. [...]
2022 - 10.3389/fphar.2022.891801
Frontiers in Pharmacology, Vol. 13 (may 2022)
|
|
2023-09-15
03:23 |
|
9 p, 280.9 KB |
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis
/
Sainz, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Riera, Pau (Institut d'Investigació Biomèdica Sant Pau) ;
Moya, Patricia (Institut d'Investigació Biomèdica Sant Pau) ;
Bernal, Sara (Institut d'Investigació Biomèdica Sant Pau) ;
Casademont i Pou, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ;
Millán, Ana Milena (Institut d'Investigació Biomèdica Sant Pau) ;
Park, Hye S (Institut d'Investigació Biomèdica Sant Pau) ;
Lasa, Adriana (Institut d'Investigació Biomèdica Sant Pau) ;
Corominas, Hèctor (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by chronic arthritis that may lead to irreversible joint damage and significant disability. Patients with RA are commonly treated with Tocilizumab (TCZ), an IL-6 receptor (IL-6R) antagonist, but many patients refractorily respond to this therapy. [...]
2022 - 10.3390/pharmaceutics14091942
Pharmaceutics, Vol. 14 (september 2022)
|
|
2023-09-15
03:23 |
|
3 p, 660.7 KB |
The Metaverse in Urology : Ready for Prime Time. The ESUT, ERUS, EULIS, and ESU Perspective
/
Checcucci, Enrico (European Association of Urology) ;
Cacciamani, Giovanni Enrico (USC Institute of Urology) ;
Amparore, Daniele (San Luigi Gonzaga Hospital) ;
Gozen, Ali (Urology Heidelberg University Teaching Hospital) ;
Seitz, Christian (Vienna General Hospital) ;
Breda, Alberto (Fundació Puigvert) ;
Liatsikos, Evangelos (University of Patras) ;
Porpiglia, Francesco (San Luigi Gonzaga Hospital) ;
Universitat Autònoma de Barcelona
2022 - 10.1016/j.euros.2022.10.011
European Urology Open Science, Vol. 46 (november 2022) , p. 96-98
|
|
2023-09-15
03:23 |
|
2023-09-15
03:23 |
|
11 p, 1.1 MB |
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
/
Puig-Jové, Carlos (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Julve i Gil, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Castelblanco, Esmeralda (Washington University School of Medicine) ;
Julián, María Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Amigó, Núria (Universitat Rovira i Virgili) ;
Andersen, Henrik U (Steno Diabetes Center Copenhagen) ;
Ahluwalia, Tarunveer S (University of Copenhagen) ;
Rossing, Peter (University of Copenhagen) ;
Mauricio, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Jensen, Magnus T (Copenhagen University Hospital Amager Hvidovre) ;
Alonso Pedrol, Núria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Subjects with Type 1 diabetes mellitus (T1DM) have an increased incidence of heart failure (HF). Several pathophysiological mechanisms have been involved in its development. The aim of this study was to analyze the potential contribution of the advanced lipoprotein profile and plasma glycosylation (GlycA) to the presence of subclinical myocardial dysfunction in subjects with T1DM. [...]
2022 - 10.1186/s12933-022-01652-z
Cardiovascular diabetology, Vol. 21 (november 2022)
|
|
2023-09-15
03:23 |
|
4 p, 880.7 KB |
β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease
/
Mohaupt, Pablo (Université de Montpellier) ;
Pons, Marie-Laure (Université de Montpellier) ;
Vialaret, Jérôme (Université de Montpellier) ;
Delaby, Constance (Institut d'Investigació Biomèdica Sant Pau) ;
Hirtz, Christophe (Université de Montpellier) ;
Lehmann, Sylvain (Université de Montpellier) ;
Universitat Autònoma de Barcelona
Synaptic degeneration is an early event closely associated with the course of Alzheimer's disease (AD). The identification of synaptic blood biomarkers is, therefore, of great interest and clinical relevance. [...]
2022 - 10.1186/s13195-022-01125-1
Alzheimer's research & therapy, Vol. 14 (november 2022)
|
|
2023-09-13
03:37 |
|
10 p, 5.7 MB |
Reassessment of the electrical connection between the pulmonary veins and the left atrium : A study to determine the different contributions of myocardial fibers along the standard ablation circumference
/
Campos, Bieito (Institut d'Investigació Biomèdica Sant Pau) ;
Alonso-Martin, Concepción (Institut d'Investigació Biomèdica Sant Pau) ;
Guerra, José M. (Institut d'Investigació Biomèdica Sant Pau) ;
Moreno-Weidmann, Zoraida (Institut d'Investigació Biomèdica Sant Pau) ;
Méndez-Zurita, Francisco (Institut d'Investigació Biomèdica Sant Pau) ;
Montiel-Quintero, Rodolfo (Institut d'Investigació Biomèdica Sant Pau) ;
Betancur-Gutiérrez, Andrés (Institut d'Investigació Biomèdica Sant Pau) ;
Viñolas, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez-Font, Enrique (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Circumferential ablation around the ipsilateral pulmonary veins (PVs) is the standard strategy for atrial fibrillation ablation. The present study seeks to assess which regions of the standard ablation circumference are the main contributors to the venoatrial electrical connection. [...]
2023 - 10.3389/fcvm.2023.1162197
Frontiers in Cardiovascular Medicine, Vol. 10 (june 2023)
|
|
|
|
guest ::
Usage statistics
Most popular
